Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS North America Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Preview AMS TV
Features
AMS Features
News & Publications
AMS Bookstore
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis: results of a structured survey
By
- AMS
posted
Oct 16, 2020 07:15 AM
0
Recommend
.
0 comments
0 views
Permalink
Related Content
Real world use of biologic drug levels and anti-drug antibodies in patients with psoriasis – does therapeutic drug monitoring have a place in routine clinical practice?
- AMS
Added Mar 15, 2021
Blog Entry
Psoriasis drugs in the medicare population: dermatologists’ spending and prescription patterns
- AMS
Added Jan 21, 2021
Blog Entry
Predictors of drug survival of biologic therapies in psoriasis patients
- AMS
Added May 13, 2020
Blog Entry
Medical Aesthetics Explained with Dermatologist Dr. Klaus Hoffmann
- AMS
Added Jun 14, 2023
Blog Entry
A survey of psoriasis patients on biologics during COVID-19: a single centre experience
- AMS
Added May 26, 2020
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic